Mahajan Imaging & Labs has partnered with Neuberg Diagnostics in a joint venture to revolutionize pathology and wellness services across North India through an integrated diagnostic pathway.

  • Strategic JV between Mahajan Imaging & Labs and Neuberg Diagnostics.
  • Expansion of pathology, radiology, and genomics services in North India.
  • Creation of a single, integrated diagnostic pathway for clinicians and patients.

NEW DELHI: In a significant move for the healthcare sector, integrated diagnostic provider Mahajan Imaging & Labs has officially entered into a joint venture partnership with Neuberg Diagnostics. This collaboration is designed to aggressively expand pathology and wellness services, specifically targeting the North Indian market.

The partnership leverages the unique strengths of both entities. Mahajan Imaging brings its deep-rooted expertise in radiology, nuclear medicine, PET-CT, and advanced diagnostics, with a strong presence in Delhi-NCR and Jaipur. Conversely, Neuberg Diagnostics contributes its extensive pathology and genomics capabilities, backed by multi-market operational experience across India, the UAE, South Africa, and the USA.

Read Also:India's GDP Growth Hits 7.8%: An In-depth Analysis of Economic Drivers

Why This Matters

BozokMedia analysis shows that the diagnostic landscape is shifting from fragmented services to integrated ecosystems. Traditionally, patients have had to visit different facilities for imaging and bloodwork. This joint venture eliminates that friction, creating a streamlined workflow that benefits both doctors and patients.

The partnership aims to make diagnostics more accessible and affordable through greater integration across pathology and imaging.

Harsh Mahajan, Founder and Chairman of Mahajan Imaging & Labs, emphasized that the goal is to scale up pathology services without compromising on the high quality the brand is known for. By tapping into Neuberg’s specialized expertise, Mahajan Imaging intends to accelerate its infrastructure and technological capabilities.

The structural core of this venture is the 'integrated diagnostic pathway.' Instead of disparate testing, the combined network will offer end-to-end testing—from routine blood work to advanced molecular tests and PET-CT—all under coordinated protocols and shared digital systems. This integration is expected to significantly reduce turnaround times and minimize errors caused by manual handling.

Historical Background

The diagnostic industry in India has transitioned from basic laboratory testing to highly complex genomic and molecular diagnostics. As chronic diseases rise, the demand for precise, integrated reporting—where imaging findings are correlated with biological markers—has become a critical requirement for modern clinical practice.

Did You Know?: Integrated diagnostic workflows can reduce the time required for complex clinical decision-making by up to 40%.

Frequently Asked Questions

1. Which regions will benefit most from this partnership?
The immediate impact will be felt in Delhi-NCR and nearby cities, with a broader expansion planned across North India.

2. How does this improve patient care?
It provides a single point of contact for all diagnostic needs, resulting in faster, more consolidated reports that link imaging with genomic data.